Bile duct cancer
Clinical trials for Bile duct cancer explained in plain language.
Never miss a new study
Get alerted when new Bile duct cancer trials appear
Sign up with your email to follow new studies for Bile duct cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Which stent lasts longest? a Head-to-Head test for bile duct blockage
Disease control OngoingThis trial is testing three types of metal stents used to relieve jaundice in people with advanced cancer blocking the bile duct. The stents – uncovered, partially covered, or fully covered – are placed during an endoscopic procedure to keep the duct open. The study will compare …
Matched conditions: BILE DUCT CANCER
Sponsor: Region Stockholm • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New cocktail of drugs shows promise for Tough-to-Treat bile duct cancer
Disease control OngoingThis study tests a combination of four drugs (gemcitabine, cisplatin, quemliclustat, and zimberelimab) as a first treatment for people with advanced biliary tract cancers, including bile duct cancer. The goal is to see if this mix can slow cancer growth and help people live longe…
Matched conditions: BILE DUCT CANCER
Phase 2 • Sponsor: Nataliya Uboha • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Chemotherapy sprayed directly into the abdomen: a new attack on stubborn cancers
Disease control OngoingThis phase 1 trial tests a new method of delivering chemotherapy for people with cancers that have spread to the lining of the abdomen (peritoneal carcinomatosis) from gastrointestinal cancers like colorectal, stomach, or pancreatic cancer. The drug, nanoliposomal irinotecan (Oni…
Matched conditions: BILE DUCT CANCER
Phase 1 • Sponsor: University Hospital, Ghent • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Keytruda takes on 15 advanced cancers in major trial
Disease control OngoingThis phase 2 trial tests the immunotherapy drug pembrolizumab (Keytruda) in people with 15 types of advanced solid tumors that have worsened after standard treatments. About 1,600 participants receive the drug to see if their tumors shrink or stop growing. The study also looks fo…
Matched conditions: BILE DUCT CANCER
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC